JPWO2023205245A5 - - Google Patents
Info
- Publication number
- JPWO2023205245A5 JPWO2023205245A5 JP2024561630A JP2024561630A JPWO2023205245A5 JP WO2023205245 A5 JPWO2023205245 A5 JP WO2023205245A5 JP 2024561630 A JP2024561630 A JP 2024561630A JP 2024561630 A JP2024561630 A JP 2024561630A JP WO2023205245 A5 JPWO2023205245 A5 JP WO2023205245A5
- Authority
- JP
- Japan
- Prior art keywords
- oral
- tablets
- group
- compound
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263333391P | 2022-04-21 | 2022-04-21 | |
| US63/333,391 | 2022-04-21 | ||
| PCT/US2023/019112 WO2023205245A1 (en) | 2022-04-21 | 2023-04-19 | Gamma-hydroxybutyrate delivering compounds and processes for making and using them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025513298A JP2025513298A (ja) | 2025-04-24 |
| JP2025513298A5 JP2025513298A5 (https=) | 2026-04-08 |
| JPWO2023205245A5 true JPWO2023205245A5 (https=) | 2026-04-08 |
Family
ID=86332306
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561629A Pending JP2025513297A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
| JP2024561630A Pending JP2025513298A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
| JP2024561627A Pending JP2025513295A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
| JP2024561628A Pending JP2025513296A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561629A Pending JP2025513297A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561627A Pending JP2025513295A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
| JP2024561628A Pending JP2025513296A (ja) | 2022-04-21 | 2023-04-19 | ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US20230338543A1 (https=) |
| EP (4) | EP4511122A1 (https=) |
| JP (4) | JP2025513297A (https=) |
| KR (4) | KR20250005145A (https=) |
| CN (4) | CN118974001A (https=) |
| AU (4) | AU2023255392A1 (https=) |
| CA (4) | CA3249689A1 (https=) |
| CL (4) | CL2024003173A1 (https=) |
| IL (4) | IL314432A (https=) |
| MA (4) | MA66991A1 (https=) |
| MX (4) | MX2024012884A (https=) |
| WO (4) | WO2023205233A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119775157B (zh) * | 2024-12-11 | 2025-09-19 | 西安味品荟食品科技有限公司 | 一种呈味化合物及其制备方法及应用 |
| CN120699637B (zh) * | 2025-06-10 | 2025-12-05 | 合肥中聚和成光电材料股份有限公司 | 液晶取向剂、液晶取向膜及液晶显示元件 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4973304U (https=) | 1972-10-12 | 1974-06-25 | ||
| DE3909485A1 (de) * | 1989-03-22 | 1990-09-27 | Basf Ag | Verfahren zur herstellung von butandiol-1,4 und tetrahydrofuran |
| JP3609457B2 (ja) * | 1994-08-25 | 2005-01-12 | 三井化学株式会社 | サリチル酸誘導体、該誘導体の金属塩および感熱記録材料 |
| GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| JP4576737B2 (ja) | 2000-06-09 | 2010-11-10 | Ｊｓｒ株式会社 | 感放射線性樹脂組成物 |
| JP4838437B2 (ja) * | 2000-06-16 | 2011-12-14 | Ｊｓｒ株式会社 | 感放射線性樹脂組成物 |
| ES2383673T3 (es) * | 2000-09-22 | 2012-06-25 | Jpi Commercial, Llc | Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos |
| US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
| JP4973304B2 (ja) * | 2007-04-27 | 2012-07-11 | 日油株式会社 | １，２，３，４−シクロブタンテトラカルボン酸の製造方法 |
| WO2011057199A1 (en) * | 2009-11-06 | 2011-05-12 | Adenios, Inc. | Compositions for treating cns disorders |
| JP5531034B2 (ja) * | 2012-01-31 | 2014-06-25 | 富士フイルム株式会社 | 感光性樹脂組成物、硬化膜の形成方法、硬化膜、有機ｅｌ表示装置及び液晶表示装置 |
| US8591922B1 (en) * | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| ITMI20132041A1 (it) * | 2013-12-06 | 2015-06-07 | Ct Lab Farm Srl | Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico. |
| CN113061089A (zh) * | 2015-09-23 | 2021-07-02 | 凯瑞康宁生物工程（武汉）有限公司 | γ-羟基丁酸的前药及其组合物和用途 |
| US20200114015A1 (en) * | 2017-04-11 | 2020-04-16 | John K. Thottathil | Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS- Based Prodrugs Of Gamma-Hydroxybutyrate (GHB) And Uses Thereof |
| WO2022214025A1 (zh) * | 2021-04-08 | 2022-10-13 | 厦门赛诺邦格生物科技股份有限公司 | 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用 |
-
2023
- 2023-04-19 US US18/303,191 patent/US20230338543A1/en active Pending
- 2023-04-19 KR KR1020247034900A patent/KR20250005145A/ko active Pending
- 2023-04-19 US US18/303,200 patent/US20230382851A1/en active Pending
- 2023-04-19 CA CA3249689A patent/CA3249689A1/en active Pending
- 2023-04-19 EP EP23724491.8A patent/EP4511122A1/en active Pending
- 2023-04-19 WO PCT/US2023/019097 patent/WO2023205233A1/en not_active Ceased
- 2023-04-19 KR KR1020247034928A patent/KR20250005147A/ko active Pending
- 2023-04-19 EP EP23723750.8A patent/EP4511121A1/en active Pending
- 2023-04-19 JP JP2024561629A patent/JP2025513297A/ja active Pending
- 2023-04-19 KR KR1020247034930A patent/KR20250007517A/ko active Pending
- 2023-04-19 IL IL314432A patent/IL314432A/en unknown
- 2023-04-19 CA CA3249693A patent/CA3249693A1/en active Pending
- 2023-04-19 IL IL314438A patent/IL314438A/en unknown
- 2023-04-19 CA CA3255515A patent/CA3255515A1/en active Pending
- 2023-04-19 MA MA66991A patent/MA66991A1/fr unknown
- 2023-04-19 CN CN202380029978.8A patent/CN118974001A/zh active Pending
- 2023-04-19 AU AU2023255392A patent/AU2023255392A1/en active Pending
- 2023-04-19 AU AU2023256557A patent/AU2023256557A1/en active Pending
- 2023-04-19 EP EP23724976.8A patent/EP4511354A1/en active Pending
- 2023-04-19 IL IL314436A patent/IL314436A/en unknown
- 2023-04-19 EP EP23723334.1A patent/EP4511353A1/en active Pending
- 2023-04-19 CN CN202380030010.7A patent/CN119095833A/zh active Pending
- 2023-04-19 JP JP2024561630A patent/JP2025513298A/ja active Pending
- 2023-04-19 KR KR1020247034937A patent/KR20250008736A/ko active Pending
- 2023-04-19 MA MA66992A patent/MA66992B1/fr unknown
- 2023-04-19 US US18/303,226 patent/US12251445B2/en active Active
- 2023-04-19 MA MA66994A patent/MA66994B1/fr unknown
- 2023-04-19 AU AU2023257266A patent/AU2023257266A1/en active Pending
- 2023-04-19 IL IL314441A patent/IL314441A/en unknown
- 2023-04-19 JP JP2024561627A patent/JP2025513295A/ja active Pending
- 2023-04-19 CN CN202380029977.3A patent/CN119317617A/zh active Pending
- 2023-04-19 WO PCT/US2023/019107 patent/WO2023205241A1/en not_active Ceased
- 2023-04-19 JP JP2024561628A patent/JP2025513296A/ja active Pending
- 2023-04-19 WO PCT/US2023/019101 patent/WO2023205237A1/en not_active Ceased
- 2023-04-19 US US18/303,220 patent/US20230382881A1/en not_active Abandoned
- 2023-04-19 AU AU2023255393A patent/AU2023255393A1/en active Pending
- 2023-04-19 WO PCT/US2023/019112 patent/WO2023205245A1/en not_active Ceased
- 2023-04-19 MA MA66993A patent/MA66993A1/fr unknown
- 2023-04-19 CN CN202380029958.0A patent/CN119095832A/zh active Pending
- 2023-04-19 CA CA3249691A patent/CA3249691A1/en active Pending
-
2024
- 2024-10-17 MX MX2024012884A patent/MX2024012884A/es unknown
- 2024-10-17 MX MX2024012882A patent/MX2024012882A/es unknown
- 2024-10-17 CL CL2024003173A patent/CL2024003173A1/es unknown
- 2024-10-17 MX MX2024012885A patent/MX2024012885A/es unknown
- 2024-10-17 CL CL2024003172A patent/CL2024003172A1/es unknown
- 2024-10-17 CL CL2024003174A patent/CL2024003174A1/es unknown
- 2024-10-17 CL CL2024003171A patent/CL2024003171A1/es unknown
- 2024-10-17 MX MX2024012883A patent/MX2024012883A/es unknown
-
2025
- 2025-02-13 US US19/053,080 patent/US20250186591A1/en active Pending
- 2025-06-16 US US19/239,173 patent/US20250367299A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100745160B1 (ko) | 멜도늄 염, 그것의 제조방법 및 그것을 주성분으로 한약학적 조성물 | |
| US20120010159A1 (en) | Combination therapies with cox-2 inhibitors and treprostinil | |
| BRPI0708071A2 (pt) | derivados de catecolamina deuterada e medicamentos compreendendo os ditos compostos | |
| TWI534125B (zh) | Novel compounds, salts thereof or solvates thereof, and pharmaceutical compositions and pharmaceutical products containing the same | |
| WO2019038637A1 (en) | FORMS OF CRYSTALLINE SALT OF LEVODOPA AMIDE AND METHODS OF MAKING AND USING THEM | |
| US10759748B2 (en) | Compounds as L-cystine crystallization inhibitors and uses thereof | |
| US20220062268A1 (en) | Pharmaceutical composition for the treatment of parkinson's disease | |
| JP2020533402A5 (https=) | ||
| JPWO2023205245A5 (https=) | ||
| JPWO2023205233A5 (https=) | ||
| JPWO2023205241A5 (https=) | ||
| JPWO2023205237A5 (https=) | ||
| AU2003289841A1 (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds | |
| AU2003303040B2 (en) | Pregabalin derivatives for the treatment of fibromyalgia and other disorders | |
| CA2884173C (en) | Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen | |
| US20120065265A1 (en) | Alpha-2-delta ligands for non-restorative sleep | |
| US20250082595A1 (en) | Methods and compositions for treating parkinson’s disease | |
| CN119300814A (zh) | 5-甲氧基-2-氨基茚满(“meai”)在用于治疗可卡因成瘾的方法中的用途 | |
| HK1129040A (en) | Alpha-2-delta ligands for non-restorative sleep | |
| WO2013079204A2 (en) | 4-phenylbutyric acid for cosmetic use | |
| NZ565180A (en) | Pregabalin derivatives for the treatment of fibromyalgia and other disorders |